• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    38 Stocks Moving In Thursday's Mid-Day Session

    1/20/22 12:00:06 PM ET
    $ABSI
    $APCX
    $AUID
    $BABA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ABSI alert in real time by email

    Gainers

    • Baudax Bio, Inc. (NASDAQ:BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering.
    • Vertical Aerospace Ltd. (NYSE:EVTL) gained 29.1% to $9.50. Barclays, on Tuesday, initiated coverage on the stock with an Underweight rating and a $7 price target.
    • DatChat, Inc. (NASDAQ:DATS) shares jumped 26.8% to $3.7899 after the company signed a letter of intent to acquire Avila Security Corporation for $1 million in cash and the greater of 739,650 shares of restricted common stock or $2.5 million of restricted common stock.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) surged 17.5% to $15.80 after the company announced a partnership with Mercedes-Benz to accelerate the development of future highly automated driving technologies for Mercedes passenger cars.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) gained 17.3% to $16.08.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) rose 16.2% to $9.67.
    • Ipsidy Inc. (NASDAQ:AUID) jumped 16.2% to $8.61. authID.ai announced the launch of Verified™ Platform Version 2.4.
    • InnSuites Hospitality Trust (NYSE:IHT) rose 15.6% to $4.5791.
    • Olink Holding AB (publ) (NASDAQ:OLK) gained 14.8% to $15.00. Olink Holding said it will use Olink® Explore 3072 to analyze 1,000 patient samples from a new cohort study in China.
    • Absci Corporation (NASDAQ:ABSI) jumped 14% to $7.75. Absci recently announced a research collaboration with Merck.
    • Gamida Cell Ltd. (NASDAQ:GMDA) surged 13.9% to $3.0989. Gamida recently announced plans to initiate a rolling BLA submission for Omidubicel and a full BLA submission is on track for the first half of 2022.
    • Opera Limited (NASDAQ:OPRA) jumped 13.7% to $7.21 after the company announced a $50 million buyback.
    • Casper Sleep Inc. (NYSE:CSPR) gained 13.4% to $6.49 after the company announced stockholder approval of a merger agreement.
    • Regional Health Properties, Inc. (NYSE:RHE) shares jumped 12.5% to $4.49.
    • Sunworks, Inc. (NASDAQ:SUNW) jumped 12.1% to $2.6305.
    • IceCure Medical Ltd (NASDAQ:ICCM) rose 12.1% to $2.50 after dipping more than 10% on Wednesday.
    • Trip.com Group Limited (NASDAQ:TCOM) shares rose 11.6% to $26.20.
    • Sunrun Inc. (NASDAQ:RUN) gained 11% to $30.77.
    • JD.com, Inc. (NASDAQ:JD) rose 10.6% to $79.93. Shares of several Chinese stocks traded higher after the People's Bank of China cut key lending rates.
    • CIRCOR International, Inc. (NYSE:CIR) gained 10.2% to $26.09. CIRCOR International said Scott Buckhout will step down as President and Chief Executive Officer.
    • Bit Digital, Inc. (NASDAQ:BTBT) rose 8.6% to $5.45 after declining around 9% on Wednesday.
    • Pinduoduo Inc. (NASDAQ:PDD) shares gained 7.2% to $68.87. Shares of several Chinese stocks traded higher after the People's Bank of China cut key lending rates.
    • Alibaba Group Holding Limited (NYSE:BABA) rose 5.4% to $134.60. The People’s Bank of China (PBOC) cut key lending rates to support the Chinese economy.

    Check out these big movers of the day

    Check out these penny stocks insiders are buying

    Losers

    • China Finance Online Co. Limited (NASDAQ:JRJC) shares dipped 41.1% to $3.81 after the company announced it has received a notice of delisting from Nasdaq.
    • Star Equity Holdings, Inc. (NASDAQ:STRR) shares fell 24.7% to $1.2499 after the company reported pricing of $14.25 million underwritten public offering.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 24.3% to $4.6320 after jumping 45% on Wednesday. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.
    • Valneva SE (NASDAQ:VALN) fell 20.4% to $37.83. Valneva shares jumped 45% on Wednesday after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva's COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.
    • TaskUs, Inc. (NASDAQ:TASK) dropped 16.6% to $29.65. Spruce Point named the stock as new short call with '50% downside,' setting a $18 price target.
    • BT Brands, Inc. (NASDAQ:BTBD) fell 15.8% to $2.81.
    • Splash Beverage Group, Inc. (NYSE:SBEV) dropped 13.8% to $3.41. Splash Beverage Group jumped 22% on Wednesday after the company announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph's Grocery stores.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) dropped 12.7% to $3.9626. Revelation Biosciences said first group of patients have been dosed in Phase 2b viral challenge study to assess efficacy of intranasal REVTx-99 for the prevention of H3N2 influenza infection.
    • BTCS Inc. (NASDAQ:BTCS) dropped 12.2% to $5.69.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) shares fell 11.1% to $29.11.
    • Cardiff Oncology, Inc. (NASDAQ:CRDF) dipped 10.3% to $4.0801. Cardiff Oncology recently announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 9.5% to $0.7597. The company announced it received FDA Orphan Drug designation for its multi-antigen target T cell therapy for pancreatic cancer.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 9.3% to $4.11 after declining around 13% on Wednesday.
    • AppTech Payments Corp. (NASDAQ:APCX) dropped 8.6% to $2.0012.
    • Vaxxinity, Inc. (NASDAQ:VAXX) fell 8.3% to $7.28. Vaxxinity recently announced the first Parkinson's disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312.
    Get the next $ABSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABSI
    $APCX
    $AUID
    $BABA

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    TaskUs Inc.
    $TASK
    2/3/2026$15.00Outperform
    Wedbush
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    SoFi Technologies Inc.
    $SOFI
    2/2/2026$36.00 → $33.00Buy
    Needham
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    Sunrun Inc.
    $RUN
    1/13/2026Mkt Perform
    Raymond James
    Full Truck Alliance Co. Ltd.
    $YMM
    1/12/2026Neutral → Underweight
    Analyst
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    More analyst ratings

    $ABSI
    $APCX
    $AUID
    $BABA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABSI
    $APCX
    $AUID
    $BABA
    SEC Filings

    View All

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    2/9/26 4:45:01 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Marker Therapeutics Inc. filed SEC Form 8-K: Shareholder Director Nominations, Financial Statements and Exhibits

    8-K - Marker Therapeutics, Inc. (0001094038) (Filer)

    2/9/26 4:06:45 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Trip.com Group Limited

    6-K - Trip.com Group Ltd (0001269238) (Filer)

    2/9/26 4:01:46 PM ET
    $TCOM
    Real Estate

    $ABSI
    $APCX
    $AUID
    $BABA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved

    Ronen Tsimerman will continue as CFO until successor is appointed CAESAREA, Israel, Feb. 9, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that after nearly a decade of service with IceCure, Chief Financial Officer Ronen Tsimerman has informed the Company of his decision to leave the Company to pursue new opportunities. The Company has initiated a search for a new Chief Financial Officer and has identified compelling candidates with significant experience commercializing disruptive technolo

    2/9/26 4:30:00 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Trip.com Group Limited to Report Fourth Quarter and Full Year of 2025 Financial Results on February 25, 2026 U.S. Time

    SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Trip.com Group Limited (NASDAQ:TCOM, HKEX: 9961)), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2025 financial results on Wednesday, February 25, 2026, U.S. Time, after the market closes. Trip.com Group's management team will host a conference call at 7:00 PM U.S. Eastern Time on February 25, 2026 (or 8:00 AM on February 26, 2026 in the Hong Kong Time) following the announcement. The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived fo

    2/9/26 5:00:00 AM ET
    $TCOM
    Real Estate

    Bit Digital Inc. Reports Monthly Ethereum Treasury and Staking Metrics for January 2026

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:BTBT) ("Bit Digital" or the "Company") today announced its monthly Ethereum ("ETH") treasury and staking metrics for the month of January 2026: Key Highlights for January 2026 As of January 31, 2026, the Company held approximately 155,239.4[1] ETH.Based on a closing ETH price of approximately $2,449, as of January 31, 2026, the market value of the Company's ETH holdings was approximately $380.2 million.The Company's total average ETH acquisition price for all holdings was approximately $3,045 as of January 31, 20

    2/6/26 8:00:00 AM ET
    $BTBT
    $WYFI
    Finance: Consumer Services
    Finance

    $ABSI
    $APCX
    $AUID
    $BABA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Freiberg Steven J exercised 250,000 shares at a strike of $7.33 and sold $1,913,710 worth of shares (94,225 units at $20.31), increasing direct ownership by 36% to 588,849 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/9/26 9:00:17 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    New insider Lindsay Brigitte Ute claimed ownership of 27,431 shares (SEC Form 3)

    3 - Cardiff Oncology, Inc. (0001213037) (Issuer)

    2/9/26 4:00:10 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ABSI
    $APCX
    $AUID
    $BABA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SoFi Technologies upgraded by Citizens with a new price target

    Citizens upgraded SoFi Technologies from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    2/9/26 6:58:53 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Wedbush initiated coverage on TaskUs with a new price target

    Wedbush initiated coverage of TaskUs with a rating of Outperform and set a new price target of $15.00

    2/3/26 7:59:13 AM ET
    $TASK
    EDP Services
    Technology

    SoFi Technologies upgraded by Analyst with a new price target

    Analyst upgraded SoFi Technologies from Neutral to Overweight and set a new price target of $31.00

    2/3/26 6:51:21 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ABSI
    $APCX
    $AUID
    $BABA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    EVP GBUL Borrow Schuppenhauer Eric bought $99,650 worth of shares (5,000 units at $19.93), increasing direct ownership by 2% to 228,768 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/5/26 5:53:28 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Chief Executive Officer Eberwein Jeffrey E. sold $39,794 worth of Series A Preferred Stock (4,365 units at $9.12) and bought $81,503 worth of shares (7,268 units at $11.21), increasing direct ownership by 27% to 1,007,824 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/31/25 5:02:24 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $ABSI
    $APCX
    $AUID
    $BABA
    Leadership Updates

    Live Leadership Updates

    View All

    IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved

    Ronen Tsimerman will continue as CFO until successor is appointed CAESAREA, Israel, Feb. 9, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that after nearly a decade of service with IceCure, Chief Financial Officer Ronen Tsimerman has informed the Company of his decision to leave the Company to pursue new opportunities. The Company has initiated a search for a new Chief Financial Officer and has identified compelling candidates with significant experience commercializing disruptive technolo

    2/9/26 4:30:00 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Vertical Aerospace Selects Evolito as Electric Propulsion Unit Partner for Valo

    Evolito to supply electric propulsion units for Valo, Vertical's commercial aircraft Companies to jointly certify the electric engines with UK CAA and EASA Evolito joins Honeywell, Syensqo and Aciturri as key suppliers, strengthening Valo's path to commercialization Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced a new long-term partnership with Evolito, a leader in high-performance electric propulsion systems, to supply electric propulsion units ("EPUs") - electric engines - that will power Valo, Vertical's commercial eVTOL aircraft. This press release features multimedia. V

    2/5/26 4:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABSI
    $APCX
    $AUID
    $BABA
    Financials

    Live finance-specific insights

    View All

    Trip.com Group Limited to Report Fourth Quarter and Full Year of 2025 Financial Results on February 25, 2026 U.S. Time

    SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Trip.com Group Limited (NASDAQ:TCOM, HKEX: 9961)), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2025 financial results on Wednesday, February 25, 2026, U.S. Time, after the market closes. Trip.com Group's management team will host a conference call at 7:00 PM U.S. Eastern Time on February 25, 2026 (or 8:00 AM on February 26, 2026 in the Hong Kong Time) following the announcement. The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived fo

    2/9/26 5:00:00 AM ET
    $TCOM
    Real Estate

    Opera's fourth quarter revenue and adjusted EBITDA expected to exceed guidance; full-year revenue growth surpasses 26%

    OSLO, Norway, Feb. 2, 2026 /PRNewswire/ -- Opera Limited (NASDAQ:OPRA), a leading global browser and AI agent company, today announced that it expects fourth quarter 2025 results to come in above its previously issued guidance ranges for both revenue and adjusted EBITDA. The company expects fourth-quarter revenue to exceed $170 million, compared to prior guidance of $162 – 165 million. As a result, full-year revenue is expected to be above $608 million, growing by over 26%, or approximately $130 million, compared to 2024. Opera also expects adjusted EBITDA to surpass the high

    2/2/26 7:00:00 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    Sunrun Announces Date for Fourth Quarter and Full-year 2025 Earnings Report

    SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Sunrun (NASDAQ:RUN) today announced that it will issue its fourth quarter and full-year 2025 earnings report after the market closes on Thursday, February 26, 2026. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at https://investors.sunrun.com or over the phone by dialing (877) 407-5989 (toll-free) or (201) 689-8434 (toll). An audio replay will be available following the call on the Sunrun Investor Relations website for approximately one month. A transcript of the conference call will also be posted to the Su

    1/28/26 8:00:00 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $ABSI
    $APCX
    $AUID
    $BABA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Opera Limited

    SC 13D/A - Opera Ltd (0001737450) (Subject)

    12/6/24 6:15:42 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Full Truck Alliance Co. Ltd.

    SC 13G/A - Full Truck Alliance Co. Ltd. (0001838413) (Subject)

    12/3/24 4:30:33 PM ET
    $YMM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Vertical Aerospace Ltd.

    SC 13D/A - Vertical Aerospace Ltd. (0001867102) (Subject)

    11/25/24 5:13:22 PM ET
    $EVTL
    Aerospace
    Industrials